Birgitta Sjöholm

Genetic Alteration of α2C-Adrenoceptor Expression in Mice: Influence on Locomotor, Hypothermic, and Neurochemical Effects of Dexmedetomidine, a Subtype-Nonselective α2-Adrenoceptor Agonist

Jukka Sallinen, Richard E. Link, Antti Haapalinna et al. · Molecular Pharmacology · 1997 · 170 citations

Recombinant human α2-adrenoceptor subtypes: comparison of [3H]rauwolscine, [3H]atipamezole and [3H]RX821002 as radioligands

Marjo Halme, Birgitta Sjöholm, Juha‐Matti Savola et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1995 · 67 citations

Molecular Pharmacology, Adrenal Gland, Molecular Physiology +6

Characterization of [3H]atipamezole as a radioligand for α2-adrenoceptors

Birgitta Sjöholm, Ritva Voutilainen, Kirsti Luomala et al. · European Journal of Pharmacology · 1992 · 33 citations

Pharmacology, Receptor (Biochemistry), Mechanism Of Action

Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons

Markku Koulo, Birgitta Sjöholm, Jaakko Lappalainen et al. · European Journal of Pharmacology · 1989 · 28 citations

Serotonin Metabolism, Nigrostriatal Dopaminergic Neurons, Neurophysiology +11

Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.

Jaakko Lappalainen, Jarmo Hietala, Markku Koulu et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 28 citations